Total Synthesis of Pargamicin A
- PMID: 36516292
- PMCID: PMC10680435
- DOI: 10.1021/acs.orglett.2c03861
Total Synthesis of Pargamicin A
Abstract
We report the total synthesis and configurational assignment of pargamicin A, a highly oxidized nonribosomal peptide that potently inhibits the growth of drug-resistant bacteria. Our synthetic approach relies on late-stage piperazine ring formation and careful selection of condensation reagents to assemble the densely substituted hexapeptide backbone. This work enables the synthesis of pargamicin congeners for the development of structure-activity relationships and informs strategies for accessing other sterically congested piperazic acid-containing natural products.
Figures
References
-
- World Health Organisation (May 26, 2015) "Global action plan on Antimicrobial resistance". Retreived from: https://ahpsr.who.int/publications/i/item/global-action-plan-on-antimicr....
- Centers for Disease Control and Prevention (2019) "Antibiotic resistance threats in the United States." Retrieved from: https://www.cdc.gov/drugresistance/biggest-threats.html
-
- Furuno JP; Perencevich EN; Johnson JA; Wright MO; McGregor JC; Morris JG Jr.; Strauss SM; Roghman MC; Nemoy LL; Standiford HC; Hebden JN; Harris AD Methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococci co-colonization. Emerg. Infect. Dis 2005, 11, 1539–1544. - PMC - PubMed
- Yoon YK; Lee MJ; Ju Y; Lee SE; Yang KS; Sohn JW; Kim MJ Determining the clinical significance of co-colonization of vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus in the intestinal tracts of patients in intensive care units: a case-control study. Ann. Clin. Microbiol. Antimicrob 2019, 18, 28. - PMC - PubMed
-
- Sun Y; Cai Y; Liu X; Bai N; Liang B; Wang R The emergence of clinical resistance to tigecycline. Int. J. Antimicrob. Agents 2013, 41, 110–116. - PubMed
- Tian Y; Li T; Zhu Y; Wang B; Zou X; Li M Mechanisms of linezolid resistance in staphylococci and enterococci isolated from two teaching hospitals in Shanghai, China. BMC Microbiol. 2014, 14, 292. - PMC - PubMed
- Miller WR; Bayer AS; Arias CA Mechanism of Action and Resistance to Daptomycin in Staphylococcus aureus and Enterococci. Cold Spring Harb. Perspect. Med 2016, 6. - PMC - PubMed
- Malbruny B; Canu A; Bozdogan B; Fantin B; Zarrouk V; Dutka-Malen S; Feger C; Leclercq R Resistance to quinupristin-dalfopristin due to mutation of L22 ribosomal protein in Staphylococcus aureus. Antimicrob. Agents Chemother 2002, 46, 2200–2207. - PMC - PubMed
-
- Süssmuth RD; Mainz A Nonribosomal Peptide Synthesis—Principles and Prospects. Angew. Chem. Int. Ed 2017, 56, 3770–3821. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
